Table 1 Baseline characteristics and clinical findings of patients referred to DVT direct-access pathwaya (N = 449)
Direct-access Yes-no strategy (N = 318) N (%) | Direct-access Follow-up strategy (N = 131) N (%) | p-value | Total (N = 449) N (%) | |
|---|---|---|---|---|
Age | 64 (50–75)b | 67 (56–74)b | 0,026 | 65 (52–74)b |
Female | 193 (61) | 63 (48) | 0,014 | 256 (57) |
DVT after initial CUSa | 48 (15) | 51 (39) | < 0.001 | 99 (22) |
Control CUS (N (%)) | 41 (13) | 22 (17) | 0,279 | 63 (14) |
DVT after Control CUS | 6 (15) | 0 (0) | 0,065 | 6 (1) |
DVT during follow-up | 2 (0.4) | 0 (0) | 0,363 | 2 (0.4) |
Pulmonary embolism during follow-up | 0 (0) | 0 (0) | – | 0 (0) |
Death during follow-up | 2 (0.5) | 2 (1,5) | 0,357 | 4 (0.9) |